Researchers have uncovered a link between molnupiravir, an antiviral drug for COVID-19, and a pattern of mutations in the SARS-CoV-2 virus. Using global...
By not disclosing milestone dollars that may or may never materialize, Exelixis showed Insilico Medicine CEO Alex Zhavoronkov, PhD, that its PR folks were...
Monday, July 31, 2023 Credit: Pfizer EMBARGOED FOR RELEASE Monday, July 31, 2023 Noon EDT Contact NIH Office of Communications and Public Liaison NIH News...
Insilico Medicine, a clinical-stage biotech company powered by generative AI, today announces that China National Medical Products Administration (NMPA)...
9 Things You Need To Know About Paxlovid Authored by Dr. Yuhong Dong via The Epoch Times (emphasis ours), Do you know when Paxlovid should...
It is becoming increasingly clear that we have misunderstood SARS-CoV-2, the virus that causes COVID-19. Many people, including some experts in the scientific...
NASH and Covid-focused Aligos Therapeutics announced that it is reorganizing its pipeline and cutting around 10% of its staff to extend its cash resources...
Some things that come in threes are seen in a positive light. But threes also have their dark side, as evidenced by the so-called tripledemic—the unprecedented...
It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t...
NICE has recommended that three COVID-19 therapies can continue to be used to treat patients – Pfizer’s Paxlovid, The post NICE rejects five COVID...
"Severe Adverse Effects": Doctors Warn Pfizer's Paxlovid Can Interact With Common Medications Pfizer's Covid-19 treatment that's definitely...
A UK study has found that Merck & Co’s oral COVID-19 therapy Lagevrio was unable to reduce hospitalisations The post Merck’s Lagevrio ‘no better...
This guidance replaces previous conditional recommendations for the use of these drugs and is based on emerging evidence that they’re not likely to work...
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available The post Dr. B: Expanding the business...
Access to free COVID-19 test kits is coming to an end in the US this week – but The post COVID-19 money could run out in...
The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, The post Moderna sues...
US startup Dr B – formed in 2021 to help match patients seeking a COVID-19 vaccine to suppliers The post Dr B raises $8m for telehealth...
We hear a lot about drug-resistant bacteria. The same thing can happen with viruses.
With record-breaking revenues and profits accruing on the back of its COVID-19 products, Pfizer is planning a big The post Pfizer heading for purple patch...
The US government has placed a contract for 66 million doses of Moderna’s Covid-19 vaccine booster candidate, and the deal could balloon to another 234...
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began...
Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after The post FDA backs pharmacist prescribing...
A new National Institutes of Health (NIH) funded study sheds new light on the waning effectiveness of Pfizer’s Paxlovid to prevent patient hospitalizations...
US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid The post Enanta lawsuit claims Pfizer’s...
Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after...
Pfizer Stops Enrollment In COVID-Pill Trial After Latest Lousy Results Authored by Mimi Nguyen Ly via The Epoch Times, Pfizer has announced...
It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment The post Six months after authorization, what do...
Galectin Therapeutics (NASDAQ: GALT), Galecto Biotech (NASDAQ: GLTO), and BioXyTran Inc. (OTCMKTS: BIXT)—these three companies all currently have market...
US pharma giant Pfizer has said it will sell some of its patented medicines at non-profit prices to The post Pfizer makes non-profit pledge for low-income...
NEW YORK, May 24, 2022 — Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced...